Elon Musk's Neuralink Gets Green Light To Launch Brain Chip Trial In Canada: 'Recruitment Is Now Open'

Neuralink, the brain implant company founded by Elon Musk, has received approval from Health Canada to launch its first clinical trial in the country.

What Happened: On Wednesday, University Health Network announced that the trial would occur at Toronto Western Hospital.

UHN CEO Kevin Smith said the hospital would be the “first and exclusive” site for the trial in Canada, although he did not specify when it would begin.

Neuarlink's official account on X, formerly Twitter, also shared the development on the site, adding, "Recruitment is now open."

See Also: Elon Musk Says Neuralink’s ‘First Order Of Business’ Is Solving Neuron Damage ‘For People…Like Stephen Hawking’

The Musk-led company is recruiting patients with quadriplegia due to conditions like ALS (Amyotrophic Lateral Sclerosis) or spinal cord injuries.